Biotech company developing drug to extend lifespan of large dogs
CBSN
All dogs may go to heaven, but one biotech startup is looking to keep labradors and other bigger canines on Earth longer.
A drug to extend the lifespan of large dogs — who live about half as long as smaller breeds — could be on the market in coming years, according to Loyal, a San Francisco biotech company developing longevity treatments for canines.
The Food and Drug Administration Center for Veterinary Medicine has found a reasonable expectation of effectiveness for the drug, codenamed LOY-001, Loyal announced Tuesday in a news release, a big step toward its full approval. The development is "a first for any longevity drug, and is a big step towards accelerating the path for canines, and ultimately humans," stated Vinod Khosla, founder of Khosla Ventures, an investor in Loyal.
